2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Symposium

[SY23] Symposium 23　Encyclopedic Seamless Drug Development for Organ Agnostic Oncology Precision Medicine - Frontline therapeutics of targeting BRCA（HRD）, PARP, HER2 and NTRK genetic alteration -
【E】

Fri. Feb 18, 2022 8:20 AM - 9:50 AM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Kenji Tamura（Department of Medical Oncology/Innovative Cancer Center, Shimane University Hospital），Chihiro Kondoh（Department of Medical Oncology, National Cancer Center Hospital East）

[SY23-4] Tumor Agnostic Development, An Industry Perspective

○David Hyman (Department of Loxo Oncology and Lilly Oncology, Loxo Oncology at Eli Lilly)